Re: Tamoxifen for the prevention of breast cancer: current status of the National Surgical Adjuvant Breast and Bowel Project P-1 study

J Natl Cancer Inst. 2006 May 3;98(9):643; author reply 643-4. doi: 10.1093/jnci/djj167.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Antineoplastic Agents, Hormonal / therapeutic use*
  • Breast Neoplasms / epidemiology*
  • Breast Neoplasms / prevention & control*
  • Controlled Clinical Trials as Topic / standards
  • Double-Blind Method
  • Female
  • Follow-Up Studies
  • Humans
  • Incidence
  • Research Design / standards
  • Selective Estrogen Receptor Modulators / therapeutic use*
  • Tamoxifen / therapeutic use*
  • Treatment Outcome
  • United States / epidemiology

Substances

  • Antineoplastic Agents, Hormonal
  • Selective Estrogen Receptor Modulators
  • Tamoxifen